8.07
price up icon6.32%   0.48
after-market 시간 외 거래: 8.03 -0.04 -0.50%
loading
전일 마감가:
$7.59
열려 있는:
$7.41
하루 거래량:
240.08K
Relative Volume:
0.65
시가총액:
$172.23M
수익:
$155.00K
순이익/손실:
$-30.01M
주가수익비율:
-4.8323
EPS:
-1.67
순현금흐름:
$-11.98M
1주 성능:
+4.40%
1개월 성능:
+0.50%
6개월 성능:
+51.98%
1년 성능:
-26.30%
1일 변동 폭
Value
$7.41
$8.16
1주일 범위
Value
$7.07
$8.16
52주 변동 폭
Value
$4.32
$12.72

Inmune Bio Inc Stock (INMB) Company Profile

Name
명칭
Inmune Bio Inc
Name
전화
(858) 964-3720
Name
주소
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
Name
직원
17
Name
트위터
@INmuneBio
Name
다음 수익 날짜
2025-03-25
Name
최신 SEC 제출 서류
Name
INMB's Discussions on Twitter

INMB을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
INMB
Inmune Bio Inc
8.07 172.23M 155.00K -30.01M -11.98M -1.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
483.49 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
625.60 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
583.62 35.60B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
266.83 34.53B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
274.78 29.15B 3.81B -644.79M -669.77M -6.24

Inmune Bio Inc Stock (INMB) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-01-28 개시 Rodman & Renshaw Buy
2024-10-21 개시 Alliance Global Partners Buy
2024-09-27 개시 Raymond James Outperform
2024-08-22 개시 Scotiabank Sector Outperform
2023-06-01 개시 Robert W. Baird Outperform
2022-05-24 다운그레이드 B. Riley Securities Buy → Neutral
2021-07-07 재확인 Maxim Group Buy
2021-04-21 개시 B. Riley Securities Buy
2021-01-22 재확인 Maxim Group Buy
2020-09-01 개시 BTIG Research Buy
2020-07-15 재확인 H.C. Wainwright Buy
모두보기

Inmune Bio Inc 주식(INMB)의 최신 뉴스

pulisher
Apr 01, 2025

INmune Bio Presents MINDFuL Trial Data At AD/PD 2025 - Nasdaq

Apr 01, 2025
pulisher
Apr 01, 2025

INmune Bio Presents Baseline Data From MINDFuL Phase II Trial In Early Alzheimer's Disease - Nasdaq

Apr 01, 2025
pulisher
Apr 01, 2025

INmune Bio presents early Alzheimer’s trial data at AD/PD - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

INmune Bio Inc. Presents Baseline Demographics and Disease Profiles of Participants in the MINDFuL Phase II Study - The Manila Times

Apr 01, 2025
pulisher
Apr 01, 2025

INmune Bio presents early Alzheimer’s trial data at AD/PD By Investing.com - Investing.com UK

Apr 01, 2025
pulisher
Apr 01, 2025

Promising Patient Profile Emerges in Major Alzheimer's Drug Trial: 69% Carry Key Risk Gene - Stock Titan

Apr 01, 2025
pulisher
Mar 31, 2025

Raymond James maintains INmune Bio stock with $23 target By Investing.com - Investing.com Australia

Mar 31, 2025
pulisher
Mar 31, 2025

Raymond James maintains INmune Bio stock with $23 target - Investing.com India

Mar 31, 2025
pulisher
Mar 31, 2025

Raymond James Financial Inc. Takes Position in INmune Bio, Inc. (NASDAQ:INMB) - Defense World

Mar 31, 2025
pulisher
Mar 30, 2025

INmune Bio anticipates Alzheimer's trial results within 100 days while advancing therapeutic platforms - MSN

Mar 30, 2025
pulisher
Mar 29, 2025

INmune Bio, Inc. (NASDAQ:INMB) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 29, 2025
pulisher
Mar 28, 2025

INmune Bio (INMB) Eyes Landmark Developments in 2024 Amid Rising Financial Commitments - GuruFocus

Mar 28, 2025
pulisher
Mar 28, 2025

INmune Bio Inc (INMB) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - Yahoo Finance

Mar 28, 2025
pulisher
Mar 28, 2025

INmune Bio Inc (INMB) Q4 2024 Earnings Call Highlights: Strategi - GuruFocus.com

Mar 28, 2025
pulisher
Mar 28, 2025

INmune Bio Reports 2024 Financial Results and Clinical Progress - TipRanks

Mar 28, 2025
pulisher
Mar 27, 2025

Earnings call transcript: INmune Bio’s Q4 2024 results highlight innovation focus By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 27, 2025

Earnings call transcript: INmune Bio’s Q4 2024 results highlight innovation focus - Investing.com India

Mar 27, 2025
pulisher
Mar 27, 2025

INmune Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025
pulisher
Mar 27, 2025

INmune Bio Inc Reports Q4 EPS of -$0.53 and Revenue of $0.01 Mil - GuruFocus.com

Mar 27, 2025
pulisher
Mar 27, 2025

INMUNE BIO Earnings Results: $INMB Reports Quarterly Earnings - Nasdaq

Mar 27, 2025
pulisher
Mar 27, 2025

INmune Bio Inc. Announces Year End 2024 Results and Provides a Business Update - TradingView

Mar 27, 2025
pulisher
Mar 27, 2025

INmune Bio's Triple Threat: Alzheimer's Trial Fully Enrolled, FDA Designations Secured - Stock Titan

Mar 27, 2025
pulisher
Mar 27, 2025

(INMB) On The My Stocks Page - news.stocktradersdaily.com

Mar 27, 2025
pulisher
Mar 26, 2025

What to Expect from INmune Bio's Earnings - Benzinga

Mar 26, 2025
pulisher
Mar 24, 2025

INmune Bio Inc. to Report Fourth Quarter 2024 Financial Results and Provide Corporate Update on March 27, 2025 - The Manila Times

Mar 24, 2025
pulisher
Mar 24, 2025

INmune Bio Sets Key Q4 Earnings Date: Critical Updates Expected for Clinical Pipeline - Stock Titan

Mar 24, 2025
pulisher
Mar 21, 2025

Undercovered Dozen: INmune Bio, Primerica, First Quantum, Pinnacle West + - Seeking Alpha

Mar 21, 2025
pulisher
Mar 20, 2025

INmune Bio (INMB) Projected to Post Quarterly Earnings on Thursday - Defense World

Mar 20, 2025
pulisher
Mar 18, 2025

INmune Bio: CORDStrom Is A Game-Changer, As Investors Await Alzheimer's Results (INMB) - Seeking Alpha

Mar 18, 2025
pulisher
Mar 13, 2025

Analysts Set INmune Bio, Inc. (NASDAQ:INMB) Target Price at $22.80 - Defense World

Mar 13, 2025
pulisher
Mar 11, 2025

INmune Bio, Inc. (NASDAQ:INMB) Position Lifted by Rhumbline Advisers - Defense World

Mar 11, 2025
pulisher
Mar 09, 2025

Protalix BioTherapeutics (NYSE:PLX) and INmune Bio (NASDAQ:INMB) Head-To-Head Review - The AM Reporter

Mar 09, 2025
pulisher
Mar 06, 2025

(INMB) Investment Analysis - Stock Traders Daily

Mar 06, 2025
pulisher
Mar 04, 2025

INmune Bio Reports Promising Phase I/II Trial Results - TipRanks

Mar 04, 2025
pulisher
Mar 03, 2025

PMGC Holdings Ends License Agreement with INmune Bio By Investing.com - Investing.com South Africa

Mar 03, 2025
pulisher
Mar 03, 2025

PMGC Holdings Ends License Agreement with INmune Bio - Investing.com

Mar 03, 2025
pulisher
Mar 03, 2025

Why INmune Bio, Inc. (INMB) is Skyrocketing So Far in 2025 - MSN

Mar 03, 2025
pulisher
Mar 01, 2025

Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025 - Insider Monkey

Mar 01, 2025
pulisher
Feb 27, 2025

Is INmune Bio (NASDAQ:INMB) A Risky Investment? - Simply Wall St

Feb 27, 2025
pulisher
Feb 24, 2025

INmune Delivers Impressive 100% Gain In Just 3 MonthsIs There More Room To Run? - RTTNews

Feb 24, 2025
pulisher
Feb 23, 2025

Learn to Evaluate (INMB) using the Charts - Stock Traders Daily

Feb 23, 2025
pulisher
Feb 21, 2025

INmune Bio, Inc. to Host Earnings Call - ACCESS Newswire

Feb 21, 2025
pulisher
Feb 20, 2025

INmune Bio, Inc. (NASDAQ:INMB) most popular amongst individual investors who own 36% of the shares, institutions hold 28% - Yahoo Finance

Feb 20, 2025
pulisher
Feb 20, 2025

INmune Bio, Inc. (NASDAQ:INMB) Receives Consensus Rating of “Buy” from Brokerages - Armenian Reporter

Feb 20, 2025
pulisher
Feb 20, 2025

INmune Bio, Inc. (NASDAQ:INMB) Short Interest Update - MarketBeat

Feb 20, 2025
pulisher
Feb 18, 2025

INmune Bio, Inc. (NASDAQ:INMB) Sees Significant Growth in Short Interest - Defense World

Feb 18, 2025
pulisher
Feb 18, 2025

INmune Bio, Inc. (NASDAQ:INMB) Receives $21.00 Consensus Price Target from Analysts - Defense World

Feb 18, 2025
pulisher
Feb 16, 2025

INmune Bio (NASDAQ:INMB) Stock Price Expected to Rise, Maxim Group Analyst Says - MarketBeat

Feb 16, 2025
pulisher
Feb 16, 2025

INmune Bio, Inc. (NASDAQ:INMB) Receives $21.00 Consensus Price Target from Brokerages - Defense World

Feb 16, 2025
pulisher
Feb 16, 2025

INmune Bio, Inc. (NASDAQ:INMB) Receives $21.00 Average Price Target from Brokerages - MarketBeat

Feb 16, 2025

Inmune Bio Inc (INMB) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$73.44
price up icon 2.00%
$68.32
price up icon 0.56%
$31.28
price up icon 0.35%
$20.46
price up icon 8.83%
$93.32
price up icon 3.36%
biotechnology ONC
$274.78
price up icon 1.38%
자본화:     |  볼륨(24시간):